Analyst revises estimates for NVTS after in line Q1 results, with $14.02M sales beating estimated $13.99M. Q2 sales expected at $14M-$15M vs consensus $14.95M.
Latest Ratings for NVTS
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2022 | Rosenblatt | Initiates Coverage On | Buy | |
| Feb 2022 | Needham | Initiates Coverage On | Buy | |
| Dec 2021 | B of A Securities | Initiates Coverage On | Neutral |
